Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,290 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PECAM is an effective and safe anthracycline-containing third-line regimen for patients with relapsed or refractory non-Hodgkin lymphoma.
Nakamura F, Arai H, Tokita K, Furuichi S, Sugita-Nagasawa F, Takahashi W, Handa T, Iso H, Tadokoro J, Tsurumi S, Nakamura Y, Nakamura Y, Sasaki K, Seo S, Ichikawa M, Mitani K. Nakamura F, et al. Among authors: nakamura y. Leuk Lymphoma. 2021 Jan;62(1):239-242. doi: 10.1080/10428194.2020.1817442. Epub 2020 Sep 11. Leuk Lymphoma. 2021. PMID: 32914680 No abstract available.
Emergence of t(3;21)(q26.2;q22) during eltrombopag treatment in a patient with relapsed aplastic anemia who received chemotherapy for angioimmunoblastic T-cell lymphoma.
Nakamura F, Nakamura Y, Nannya Y, Arai H, Shimbo K, Nakamura Y, Seo S, Sasaki K, Ichikawa M, Ogawa S, Mitani K. Nakamura F, et al. Among authors: nakamura y. Leuk Res Rep. 2022 Mar 25;17:100305. doi: 10.1016/j.lrr.2022.100305. eCollection 2022. Leuk Res Rep. 2022. PMID: 35371915 Free PMC article.
Development of Philadelphia chromosome-negative acute myeloid leukemia with IDH2 and NPM1 mutations in a patient with chronic myeloid leukemia who showed a major molecular response to tyrosine kinase inhibitor therapy.
Nakamura F, Arai H, Nannya Y, Ichikawa M, Furuichi S, Nagasawa F, Takahashi W, Handa T, Nakamura Y, Tanaka H, Nakamura Y, Sasaki K, Miyano S, Ogawa S, Mitani K. Nakamura F, et al. Among authors: nakamura y. Int J Hematol. 2021 Jun;113(6):936-940. doi: 10.1007/s12185-020-03074-7. Epub 2021 Jan 5. Int J Hematol. 2021. PMID: 33400143
Risk of admission requirement among children with respiratory infection in the post-COVID-19 pandemic era.
Mori T, Kitano T, Kitagawa D, Murata M, Onishi M, Hachisuka S, Okubo T, Yamamoto N, Nishikawa H, Onaka M, Suzuki R, Sekine M, Suzuki S, Nakamura F, Yoshida S. Mori T, et al. Among authors: nakamura f. J Infect Public Health. 2024 Dec;17(12):102570. doi: 10.1016/j.jiph.2024.102570. Epub 2024 Oct 28. J Infect Public Health. 2024. PMID: 39481292 Free article.
1,290 results